Just In
- 3 hrs ago 7 Questions You Should Ask Your Partner Before Getting Into An Arranged Marriage
- 6 hrs ago Heeramandi: Designers Rimple And Harpreet Craft Inspiring 300 Outfits, Know The Details Here!
- 10 hrs ago These Common Habits Can Be Insidious, Can Hurt Any Partner And Ruin Any Relationship
- 13 hrs ago What Is Porcelain Doll Makeup Trend? 6 Tips To Achieve The Doll-like Glamour
Don't Miss
- News Jailed Former Maldives President Abdulla Yameen Released, Court Orders Fresh Trial In Bribe Case
- Sports Pakistan vs New Zealand: Babar Azam, Shaheen Afridi Heartwarming Hug Amidst Speculations of Discord
- Finance Big News For F&O Traders! NSE To Launch Derivatives On Nifty Next 50 From April 24; Key Highlights!
- Movies Yeh Rishta Kya Kehlata Hai Controversy: YRKKH Actor Makes BIG Revelation About Shehzada Dhami: Alag Dhang Se K
- Automobiles Aprilia RS 457 Accessories: A Detailed Look At The Prices
- Education Karnataka SSLC Result 2024 Soon, Know How to Check Through Website, SMS and Digilocker
- Technology Nothing Ear, Ear a With ANC, Up to 42.5 Hours of Battery Launched; Check Price and Availability
- Travel Telangana's Waterfall: A Serene Escape Into Nature's Marvels
Covaxin's Shelf Life Extended To 12 Months From Date Of Manufacture
The Central Drugs Standard Control Organisation (CDSCO) has approved the extension of Bharat Biotech's COVID-19 vaccine Covaxin's shelf life up to 12 months from the date of manufacture, the vaccine-maker said.
"This approval of shelf life extension is based on the availability of additional stability data, which was submitted to CDSCO. With the shelf life extension, hospitals can now utilise the stock to avoid vaccine wastage", a press release said.
Covaxin is approved for use under the 28-day multi-dose vial policy from Drug Controller General of India and the WHO Emergency Use Listing (WHO EUL).
Covaxin Open Vial is stable at 2 to 8 degrees Celsius for 28 days and not required to be discarded immediately in a day or at the end of immunisation session.
Bharat Biotech said it believes in doing a bit for the environment. The multi-dose vial policy saves money for procurement agencies by reducing the cold chain logistics and management thereby reducing the carbon footprint, costs related to open vial wastage, cold chain distribution, cold chain storage and biomedical waste disposal among others.
"Most importantly, we believe in being environmentally friendly by reducing the quantity of packing materials and single-use plastics that are utilised in vaccines manufacturing, storage, distribution and disposal, '' the company said.
- healthCOVID-19 Vaccines and Heart Attacks: New Studies Show Different Results; What Are They?
- wellnessCorbevax Will Be Allowed As A Booster For Those Fully Vaccinated With Covishield Or Covaxin
- kidsCovid-19 Vaccines For Kids: DCGI Grants Emergency Use Nod To 3 Vaccines For Different Age Group Of Children
- wellnessBooster Dose Of COVID Vaccine Needed To Fight Against Omicron: Study
- wellnessIndia's Covaxin To Be Evaluated As COVID-19 Vaccine Candidate In USA
- healthCovaxin Granted Emergency Use Listing In 13 Nations As On Jan 31 According To WHO: Government
- healthEach Dose Of Covishield, Covaxin Likely To Be Capped At Rs 275 After Getting Regular Market Approval
- healthMedia Reports Stating Vaccine Shortage In Maharashtra Are Not Factually Correct: Govt
- healthGovt's Decision On COVID-19 Vaccination For Children 'Unscientific': Senior AIIMS Epidemiologist
- healthExperts Allay Covaxin Concerns, Say 50% Effectiveness Against Delta-Driven COVID-19 Surge Not Bad
- healthGovernment Nod To Commercial Export Of Covishield, Covaxin In View Of Sufficient Stock
- healthCovaxin Shows 50% Effectiveness Against Symptomatic Covid-19 In Real-World Assessment: Lancet Study